(Q43989669)

28 November 2017

title

Immunogenicity of immunoliposomes (English)

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

author name string

N. C. Phillips

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1839297

7 December 2022

A. Emili

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1839297

7 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1839297

7 December 2022

publication date

1 November 1991

1 reference

full work available at URL

28 November 2017

https://api.elsevier.com/content/article/PII:016524789190040H?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

https://api.elsevier.com/content/article/PII:016524789190040H?httpAccept=text/plain

7 December 2022

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

1 reference

28 November 2017

volume

30

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

291-296

1 reference

Liposomes in immunology: multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its own.

28 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Monoclonal antibody and liposomes

7 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions

7 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Immunoliposomes with different acid sensitivities as probes for the cellular endocytic pathway

7 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

pH-sensitive, plasma-stable liposomes with relatively prolonged residence in circulation

7 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: implications for subunit vaccines

7 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Immunospecific targeting of liposomes to cells: a novel and efficient method for covalent attachment of Fab' fragments via disulfide bonds

7 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Targeting to cells of fluorescent liposomes covalently coupled with monoclonal antibody or protein A

7 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Use of avidin-biotin technology for liposome targeting

7 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

13

46

3431

Connor

1986

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Inhibition of cell proliferation with antibody-targeted liposomes containing methotrexate-gamma-dimyristoylphosphatidylethanolamine.

7 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

17

49

4879

Matthay

1989

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Liposomes coupled with monoclonal antibodies against glioma-associated antigen for targeting chemotherapy of glioma

7 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Phototoxic liposomes coupled to an antibody that alone cannot modulate its cell-surface antigen kill selected target cells

7 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Immunospecific targeting of immunoliposomes, F(ab')2 and IgG to red blood cells in vivo

7 December 2022

20

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Effect of attachment of anticandidal antibody to the surfaces of liposomes encapsulating amphotericin B in the treatment of murine candidiasis

7 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

22

49

6214

Hughes

1989

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Characterization of in vivo immunoliposome targeting to pulmonary endothelium

7 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Liposomes as immunological adjuvants

7 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Liposomes in immunology: Evidence that their adjuvant effect results from surface exposition of the antigens

7 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen

7 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Liposomes as immunological adjuvants: antigen incorporation studies

7 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Immunoadjuvant action of liposomes: comparison with other adjuvants

7 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells

7 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Parameters affecting the immunogenicity of a liposome-associated synthetic hexapeptide antigen

7 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Liposomal vaccine: influence of antigen association on the kinetics of the humoral response

7 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Characterization of primate antibody responses to administered murine monoclonal immunoglobulin

7 December 2022

38

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

39

49

6153

Byers

1989

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208.

7 December 2022

40

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

41

50

1051s

Blottière

1990

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

42

50

1055s

Losman

1990

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Liposomes as carriers for a human malaria sporozoite vaccine

7 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Immunogenicity of ribonucleic acid-protein fraction of Mycobacterium tuberculosis encapsulated in liposomes

7 December 2022

46

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection

7 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

Use of anti-idiotypic antibody-drug conjugates to treat experimental murine B-cell tumors

7 December 2022

54

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

CD4 and CD7 molecules as targets for drug delivery from antibody bearing liposomes

7 December 2022

56

1 reference

https://api.crossref.org/works/10.1016/0165-2478(91)90040-H

7 December 2022

Identifiers

1 reference

28 November 2017

1 reference